Literature DB >> 17202148

Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1.

Meng-Huee Lee1, Susan Atkinson, Gillian Murphy.   

Abstract

Tissue inhibitor of metalloproteinases (TIMPs) are the endogenous inhibitors of the zinc-dependent endopeptidases of the matrix metalloproteinase families. There are four mammalian TIMPs (TIMP-1 to -4) but only TIMP-3 is sequestered to the extracellular matrix (ECM). The molecular basis for the TIMP-3:ECM association has never been fully investigated until now. In this report, we identify the unique amino acid configuration that constitutes the basis of the ECM binding motif in TIMP-3. By systematically exchanging the subdomains of the TIMPs and exhaustive mutation of TIMP-3, we have identified the surface residues directly responsible for ECM association. Contrary to the accepted view, we have found that TIMP-3 interacts with the ECM via both its N- and C-terminal domains. The amino acids involved in ECM binding are all basic in nature: Lys-26, Lys-27, Lys-30, Lys-76 of the N-terminal domain and Arg-163, Lys-165 of the C-terminal domain. Replacement of these residues with glutamate (E) and glutamine (Q) (K26/27/30/76E + R163/K165Q) resulted in a soluble TIMP-3 devoid of ECM-adhering ability. Using the ECM binding motif derived from TIMP-3, we have also created a TIMP-1 mutant (K26/27/30 + K76 transplant) capable of ECM association. This is the first instance of TIMPs being intentionally rendered soluble or ECM-bound. The ability to prepare TIMPs in soluble or ECM-bound forms also opens new avenues for future TIMP research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202148     DOI: 10.1074/jbc.M610490200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex.

Authors:  Linda Troeberg; Barbara Mulloy; Peter Ghosh; Meng-Huee Lee; Gillian Murphy; Hideaki Nagase
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

2.  Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women.

Authors:  Changlong Guo; Xiaofang Cao; Qidi Wang; Guangyu Wang; Lisha An; Meng Du; Yue Qiu; Ying Yang; Hui Li; Yuting Wang; Shuo Wang; Xingyu Wang; Xu Ma
Journal:  J Assist Reprod Genet       Date:  2015-08-25       Impact factor: 3.412

3.  Translocating a High-Affinity Designer TIMP-1 to the Cell Membrane for Total Renal Carcinoma Inhibition: Putting the Prion Protein to Good Use.

Authors:  Bingjie Jiang; Yuewei Xu; Yihe Zhang; Meng Huee Lee
Journal:  Mol Cell Biol       Date:  2019-08-27       Impact factor: 4.272

Review 4.  Modulatory effects of proteoglycans on proteinase activities.

Authors:  Steven Georges; Dominique Heymann; Marc Padrines
Journal:  Methods Mol Biol       Date:  2012

5.  Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.

Authors:  Anne M Macgregor; Charles G Eberhart; Mostafa Fraig; Jie Lu; Marc K Halushka
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479

6.  Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance.

Authors:  Hong-Qi Liu; Shu Song; Jian-Hua Wang; Shao-Lan Zhang
Journal:  Oncol Lett       Date:  2011-08-31       Impact factor: 2.967

7.  Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.

Authors:  Yi Shen; Ingrid G Winkler; Valerie Barbier; Natalie A Sims; Jean Hendy; Jean-Pierre Lévesque
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.

Authors:  Linda Troeberg; Kazunari Fushimi; Simone D Scilabra; Hiroyuki Nakamura; Vincent Dive; Ida B Thøgersen; Jan J Enghild; Hideaki Nagase
Journal:  Matrix Biol       Date:  2009-07-28       Impact factor: 11.583

9.  The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.

Authors:  Bowen Sun; Xiaohai Liu; Yakun Yang; Congxin Dai; Ying Li; Yonghui Jiao; Zhenqing Wei; Yong Yao; Ming Feng; Xinjie Bao; Kan Deng; Ning Wang; Renzhi Wang
Journal:  J Mol Neurosci       Date:  2015-12-16       Impact factor: 3.444

10.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.

Authors:  Marie Monet-Leprêtre; Iman Haddad; Céline Baron-Menguy; Maï Fouillot-Panchal; Meriem Riani; Valérie Domenga-Denier; Claire Dussaule; Emmanuel Cognat; Joelle Vinh; Anne Joutel
Journal:  Brain       Date:  2013-05-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.